Clinical Trial

Incidence of Fragility Fractures and Osteoporosis Screening in Chronic Stroke Patients

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 5, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Stroke is a known risk factor for the development of osteoporosis, leading to an increased risk of falls and fractures. Several international studies have associated stroke with hip fractures, showing an odds ratio ranging between 1.5 and 4. The literature frequently indicates a lack of management for bone metabolism in patients following cerebrovascular events. This study aims to evaluate the incidence of osteoporosis and fragility fractures in patients with chronic stroke. A secondary aim is to assess whether patients have been adequately screened for bone metabolism following a cerebrovascular event. This study is designed as a prospective observational study. Patients aged over 65 years with chronic stroke are assessed at the U.O.C. of "Functional Recovery and Rehabilitation" at A.O.U.P. "P. Giaccone," Palermo. During the assessment, clinical and demographic data are collected, including details of the cerebrovascular event (location, hemorrhagic/ischemic, date), pre-event and post-event disability/autonomy (Rankin scale), presence of fractures (location and date) in the patient's medical history (pre and post-event), femoral and lumbar DEXA for osteoporosis evaluation, and DeFRA for assessing the 10-year risk of fragility fractures.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-30.
Trial Details
NCT Number NCT06804252
Lead Sponsor University of Palermo
Conditions Chronic Stroke, Osteoporosis, Fragility Fractures
Enrollment 50 participants
Start Date 2024-12-10
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-05